Sequanta Technologies Co. and Mission Bio have entered into a strategic partnership, providing high-quality single-cell sequence services using Mission Bio’s products to customers in mainland China.   Mission Bio provides researchers with the tools needed to improve how we measure and predict our resistance and response to cancer therapies. Mission Bio’s multi-omics approach aims to improve time-to-market for new therapeutics, including innovative cell and gene therapies. The compa...